1. Chen, Lizhen, Lin, Zhonghua, Jiang, Man, Jiang, Xiangjun, Xuan, Shiying. 2015. Genetic Variants in the SAMM50 Gene Create Susceptibility to Nonalcoholic Fatty Liver Disease in a Chinese Han Population. In Hepatitis monthly, 15, e31076. doi:10.5812/hepatmon.31076. https://pubmed.ncbi.nlm.nih.gov/26587038/
2. Xu, Ke, Zheng, Kenneth I, Zhu, Pei-Wu, Chen, Yong-Ping, Zheng, Ming-Hua. 2021. Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis. In Journal of clinical and translational hepatology, 10, 219-229. doi:10.14218/JCTH.2021.00067. https://pubmed.ncbi.nlm.nih.gov/35528982/
3. Li, Zuyin, Shen, Weixing, Wu, Gang, Wang, Ruitao, Wang, Xiaoliang. 2021. The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms. In FEBS open bio, 11, 1893-1906. doi:10.1002/2211-5463.13146. https://pubmed.ncbi.nlm.nih.gov/33728819/
4. Xu, Ran, Kang, Le, Wei, Siang, Ding, Zhiwen, Zou, Yunzeng. 2021. Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes. In Frontiers in cardiovascular medicine, 8, 748156. doi:10.3389/fcvm.2021.748156. https://pubmed.ncbi.nlm.nih.gov/34631840/
5. Larrieta-Carrasco, Elena, Flores, Yvonne N, Macías-Kauffer, Luis R, Salmerón, Jorge, Velázquez-Cruz, Rafael. 2018. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population. In Experimental and molecular pathology, 104, 50-58. doi:10.1016/j.yexmp.2018.01.001. https://pubmed.ncbi.nlm.nih.gov/29307798/